| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/13/1998 | US5707491 Paper strengthened with solubilized collagen and method |
| 01/10/1998 | CA2206997A1 Benzothiophene compounds and methods of use |
| 01/08/1998 | WO1998000695A2 Tat-sf: cofactor for stimulation of transcriptional elongation by hiv-1 tat |
| 01/08/1998 | WO1998000556A1 Cationic polymer and lipoprotein-containing system for gene delivery |
| 01/08/1998 | WO1998000554A1 Protease fmh-1, an ice/ced-like protease |
| 01/08/1998 | WO1998000553A1 Human hyaluronidase |
| 01/08/1998 | WO1998000552A2 Receptor tyrosine phosphatase, and uses related thereto |
| 01/08/1998 | WO1998000551A2 Gene encoding hyaluronan synthase |
| 01/08/1998 | WO1998000543A1 Hepatocyte growth factor receptor agonists and uses thereof |
| 01/08/1998 | WO1998000542A2 Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia |
| 01/08/1998 | WO1998000541A2 Methods for administration of recombinant gene delivery vehicles for treatment of human disease |
| 01/08/1998 | WO1998000540A1 Human stem cell antigens, dna coding therefor and their use |
| 01/08/1998 | WO1998000538A2 Peptides and peptidomimetic compounds affecting the activity of g-protein-coupled receptors by altering receptor oligomerization |
| 01/08/1998 | WO1998000537A1 Composition and methods for modulating the length of telomeres |
| 01/08/1998 | WO1998000535A2 Method for inhibiting hiv-1 infection, drug screens, and methods of diagnosis and prognosis of susceptibility to hiv infection |
| 01/08/1998 | WO1998000532A2 Oligonucleotides from the untranslated regions of ribonucleotide reductase and their use to modulate cell growth |
| 01/08/1998 | WO1998000531A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 01/08/1998 | WO1998000528A1 A recombinant enzyme with mutanase activity |
| 01/08/1998 | WO1998000527A1 ISOLATION AND CLONING OF THE HUMAN hARSA-I GENE AND USES THEREOF |
| 01/08/1998 | WO1998000525A1 Capsid polypeptides and use to inhibit viral packaging |
| 01/08/1998 | WO1998000522A1 Method to produce granulocyte colony stimulating factor from immortalized avian t lymphocytes and method to produce immortalized cells |
| 01/08/1998 | WO1998000443A1 Thrombin inhibitors |
| 01/08/1998 | WO1998000442A1 Serine protease inhibitors |
| 01/08/1998 | WO1998000439A2 Multivalent compounds for cross-linking receptors and uses thereof |
| 01/08/1998 | WO1998000411A1 Prenyl transferase inhibitors |
| 01/08/1998 | WO1998000409A1 Inhibitors of prenyl transferases |
| 01/08/1998 | WO1998000183A2 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier |
| 01/08/1998 | WO1998000172A2 Compositions and methods for altering the biodistribution of biological agents |
| 01/08/1998 | WO1998000171A2 Conjugates of thrombin inhibitors and endogenes carriers |
| 01/08/1998 | WO1998000169A1 Hydrophobic preparations containing medium chain monoglycerides |
| 01/08/1998 | WO1998000166A1 Recombinant canine adenovirus (cav) containing exogenous dna |
| 01/08/1998 | WO1998000160A1 USE OF THIOREDOXIN-LIKE MOLECULES FOR INDUCTION OF MnSOD TO TREAT OXIDATIVE DAMAGE |
| 01/08/1998 | WO1998000159A1 Useful formulations of acid addition salt drugs |
| 01/08/1998 | WO1998000158A1 Non-aqueous polar aprotic peptide formulations |
| 01/08/1998 | WO1998000157A1 Aqueous formulations of peptides |
| 01/08/1998 | WO1998000156A1 Synthetic phosphopeptides for treating bone diseases |
| 01/08/1998 | WO1998000155A1 Stabilization and oral delivery of calcitonin |
| 01/08/1998 | WO1998000153A1 Amides |
| 01/08/1998 | WO1998000152A1 Non-aqueous protic peptide formulations |
| 01/08/1998 | WO1998000150A1 Pharmaceutical composition, comprising complement proteins, for the treatment of helicobacter infections and a method for the preparation of the composition |
| 01/08/1998 | WO1998000136A1 Virginiamycin mixture |
| 01/08/1998 | WO1998000111A1 High dose liposomal aerosol formulations |
| 01/08/1998 | WO1998000095A1 Isolated arachidonic acid-binding heteromer and its use in cosmetics and pharmaceutics |
| 01/08/1998 | WO1998000014A1 Transformation and genetherapy of cells of the inner ear |
| 01/08/1998 | WO1998000013A1 Enhancement of cancer cell death |
| 01/08/1998 | WO1997041824A3 Antiangiogenic peptides derived from plasminogen |
| 01/08/1998 | WO1997033995A3 Extracellular matrix signalling molecules |
| 01/08/1998 | WO1997026321A3 Recombinant expression of proteins from secretory cell lines |
| 01/08/1998 | DE19625642A1 Verfahren zur Herstellung einer Antidotausgangssubstanz für natürliche und synthetische Thrombininhibitoren A process for preparing a thrombin inhibitors antidote starting substance for natural and synthetic |
| 01/08/1998 | CA2259557A1 Non-aqueous polar aprotic peptide formulations |
| 01/08/1998 | CA2259505A1 Aqueous formulations of peptides |
| 01/08/1998 | CA2259403A1 Non-aqueous protic peptide formulations |
| 01/08/1998 | CA2259389A1 Composition and methods for modulating the length of telomeres |
| 01/08/1998 | CA2259298A1 Virginiamycin mixture |
| 01/08/1998 | CA2259233A1 Hydrophobic preparations containing medium chain monoglycerides |
| 01/08/1998 | CA2259208A1 Isolation and cloning of the human harsa-i gene and uses thereof |
| 01/08/1998 | CA2259139A1 Cationic polymer and lipoprotein-containing system for gene delivery |
| 01/08/1998 | CA2259135A1 Human stem cell antigens, dna coding therefor and their use |
| 01/08/1998 | CA2259132A1 Peptides and peptidomimetic compounds affecting the activity of g-protein-coupled receptors by altering receptor oligomerization |
| 01/08/1998 | CA2258965A1 Useful formulations of acid addition salt drugs |
| 01/08/1998 | CA2258796A1 Isolated arachidonic acid-binding heteromer and its use in cosmetics and pharmaceutics |
| 01/08/1998 | CA2258634A1 Serine protease inhibitors |
| 01/08/1998 | CA2258516A1 Conjugates of thrombin inhibitors and endogenes carriers |
| 01/08/1998 | CA2258291A1 A recombinant enzyme with mutanase activity |
| 01/08/1998 | CA2258286A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 01/08/1998 | CA2258038A1 Multivalent compounds for cross-linking receptors and uses thereof |
| 01/08/1998 | CA2255893A1 Prenyl transferase inhibitors |
| 01/08/1998 | CA2205554A1 Novel isoform gene for focal adhesion protein paxillin |
| 01/07/1998 | EP0816852A1 Process for measuring a collagen-binding substance, especially of the activity of an adhesion-protein |
| 01/07/1998 | EP0816510A1 Process for producing biologically active fused proteins |
| 01/07/1998 | EP0816502A2 Mur A-1, an UDP-N-acetylglucosamine enolpyruvyl-transferase from Streptococcus pneumoniae |
| 01/07/1998 | EP0816498A2 Excitatory amino acid receptor protein and related nucleic acid compounds |
| 01/07/1998 | EP0816497A2 Human requiem polypeptide for apoptosis |
| 01/07/1998 | EP0816496A2 T-cells specific for kidney carcinoma |
| 01/07/1998 | EP0816495A1 DNA coding for a peptide promoting the activation of protein C by thrombin and dprocess for producing the same |
| 01/07/1998 | EP0816494A1 DNA coding for a peptide promoting the activation of protein C by thrombin, and process for producing the same |
| 01/07/1998 | EP0816493A1 3'End deleted DNA coding for a peptide promoting the activation of protein C by thrombin, and process for producing the same |
| 01/07/1998 | EP0816492A1 Novel dnas, novel polypeptides and novel antibodies |
| 01/07/1998 | EP0816413A2 Purified polylactide and pharmaceutical composition thereof |
| 01/07/1998 | EP0816381A1 Peg-modified hgf |
| 01/07/1998 | EP0816380A1 Novel protein and methods for the production of the same |
| 01/07/1998 | EP0816379A2 DNA binding oligomers |
| 01/07/1998 | EP0816378A1 Glycopeptide antibiotic amide derivatives |
| 01/07/1998 | EP0816376A1 Trombin inhibitors as anticoagulant agents |
| 01/07/1998 | EP0816324A1 Subsituted benzyl derivatives of polyalkylene-polyamines and their use in cosmetic and pharmaceutical compositions |
| 01/07/1998 | EP0815870A2 Composition for prohylaxis or treatment of cerebral infarction |
| 01/07/1998 | EP0815869A1 Method of preventing tpo adsorption and stable tpo-containing composition |
| 01/07/1998 | EP0815856A2 Retroviral protease inhibitors |
| 01/07/1998 | EP0815450A2 Compounds and methods for the dectection of t. cruzi infection |
| 01/07/1998 | EP0815255A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae |
| 01/07/1998 | EP0815252A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
| 01/07/1998 | EP0815251A1 Gene expression in mammalian cells |
| 01/07/1998 | EP0815247A1 Method for the production of cationic peptides |
| 01/07/1998 | EP0815245A1 Bioactive fusion proteins and pre-existing tumor therapy |
| 01/07/1998 | EP0815240A1 Novel human cyclin-dependent kinase-like proteins and methods of using the same |
| 01/07/1998 | EP0815239A1 Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapy |
| 01/07/1998 | EP0815237A1 Threonyl-trna synthetase of staphylococcus aureus |
| 01/07/1998 | EP0815236A1 Haemophilus adhesion proteins |
| 01/07/1998 | EP0815234A1 Proteinase k resistant surface protein of neisseria meningitidis |
| 01/07/1998 | EP0815233A1 Novel avian cytokines and genetic sequences encoding same |